Paper7145508
C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
Gregersen N and 5 others. Pediatr Res, 1982. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Papers, record 7145508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7145508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dicarboxylic Acids | Major topic |
| Fatty Acids | Major topic |
| Lipid Metabolism, Inborn Errors | Major topic |
| Riboflavin | Major topic |
| Acyl Coenzyme A | |
| Child, Preschool | |
| Diagnosis, Differential | |
| Humans | |
| Male | |
| Reye Syndrome |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42046426 | Effectiveness of Riboflavin in Inherited Metabolic Diseases: A Systematic Review. | J Inherit Metab Dis | 2026 | https://conductscience.org/library/papers/42046426 | PubMed |
| 40444179 | Transporters in vitamin uptake and cellular metabolism: impacts on health and disease. | Life Metab | 2025 | https://conductscience.org/library/papers/40444179 | PubMed |
| 37140888 | The biochemistry and physiology of long-chain dicarboxylic acid metabolism. | Biochem J | 2023 | https://conductscience.org/library/papers/37140888 | PubMed |
| 32481712 | Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32481712 | PubMed |
| 30375113 | A 3-Month-Old Boy With Progressive Weakness. | Brain Pathol | 2018 | https://conductscience.org/library/papers/30375113 | PubMed |
| 26830983 | A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency. | Chin Med J (Engl) | 2016 | https://conductscience.org/library/papers/26830983 | PubMed |
| 22976761 | Brown-Vialetto-Van Laere and Fazio Londe syndromes: defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD). | J Inherit Metab Dis | 2012 | https://conductscience.org/library/papers/22976761 | PubMed |
| 22400091 | Evaluation of diagnostic fasting in the investigation of hypoglycemia in children omani experienc. | Oman Med J | 2007 | https://conductscience.org/library/papers/22400091 | PubMed |
| 18836889 | Mitochondrial fatty acid oxidation defects--remaining challenges. | J Inherit Metab Dis | 2008 | https://conductscience.org/library/papers/18836889 | PubMed |
| 11036031 | Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/11036031 | PubMed |
| 6725560 | L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6725560 | PubMed |
| 6651329 | Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. | Arch Dis Child | 1983 | https://conductscience.org/library/papers/6651329 | PubMed |
| 6547838 | Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. | Biochem J | 1984 | https://conductscience.org/library/papers/6547838 | PubMed |
| 6468448 | Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities. | Eur J Pediatr | 1984 | https://conductscience.org/library/papers/6468448 | PubMed |
| 6434845 | The differential diagnosis of dicarboxylic aciduria. | J Inherit Metab Dis | 1984 | https://conductscience.org/library/papers/6434845 | PubMed |
| 6434840 | Symptoms and signs in organic acidurias. | J Inherit Metab Dis | 1984 | https://conductscience.org/library/papers/6434840 | PubMed |
| 6394338 | Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin. | Eur J Pediatr | 1984 | https://conductscience.org/library/papers/6394338 | PubMed |
| 4062873 | The microsomal dicarboxylyl-CoA synthetase. | Biochem J | 1985 | https://conductscience.org/library/papers/4062873 | PubMed |
| 4031073 | Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. | J Clin Invest | 1985 | https://conductscience.org/library/papers/4031073 | PubMed |
| 3939533 | Riboflavin-responsive ethylmalonic-adipic aciduria. | J Inherit Metab Dis | 1985 | https://conductscience.org/library/papers/3939533 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7145508
GET https://conductscience.org/api/papers/v1/7145508/cited_by?page=2